期刊文献+

黄体期促排卵在卵巢低反应患者中的应用 被引量:17

Application of luteal phase ovarian stimulation in patients with poor ovarian response
下载PDF
导出
摘要 目的探讨体外受精-胚胎移植(IVF-ET)周期中,黄体期促排卵在卵巢低反应(POR)患者中的应用及临床体会。方法回顾性分析POR的227个IVF周期,分析克罗米芬微刺激阶段和后续的黄体期促排卵阶段的一般资料、获卵数、取消率、再获卵率等及冷冻胚胎移植妊娠结局等指标。总结黄体期促排卵应用于POR患者中的临床体会。结果两个阶段间MII卵率、受精率、优质胚胎率均无统计学差异(P>0.05),但黄体期促排卵阶段的平均获卵数明显高于微刺激阶段(P<0.05)。微刺激阶段及黄体期促排卵阶段所获得的冷冻胚胎进行移植后,临床妊娠率为28.8%,胚胎种植率为15%。黄体期促排卵方案的再获卵率64.4%。结论在POR患者中,黄体期促排卵方案周期获卵数及再获卵率高,能降低患者心理压力,获得较满意的临床妊娠结局,提示黄体期促排卵方案对于POR患者是一种值得尝试的促排卵方案。 Objective: To assess the efficacy of luteal phase ovarian stimulation protocol in poor ovarian responders(PORs)undergoing in vitro fertilization. Methods: A retrospective analysis was performed for 227 IVF cycles adopted mild ovarian stimulation (MOS)protocol and sequent luteal phase ovarian stimulation(LPS)protocol. The clinical data including number of retrieved oocytes, number of mature oocytes, abortion rate and pregnant outcome, etc. were analyzed. Results: The mature oocytes rate and fertilization rate were not statistically different between the MOS stage and LPS stage. Meanwhile, the good quality embryo rate was not significantly different between the two stages (P〉0.05). The frozen embryos obtained from the MOS and LPS stages were implanted. The clinical pregnancy rate and the implantation rate were 28.8% and 15% respectively. The oocytes retrieval rate in LPS stage was 64.4%. The ooeytes retrieval rate was significantly higher in LPS stage than that in MOS stage(P〈0.05). Conclusions: In poor ovarian responders,the luteal phase ovarian stimulation protocol would increase the oocytes retrieval rate and decrease the patients psychological stress. So the luteal phase ovarian stimulation protocol may be a valid alternative treatment strategy in poor ovarian responders.
出处 《生殖医学杂志》 CAS 2014年第2期131-135,共5页 Journal of Reproductive Medicine
基金 广东省医学科学技术研究基金项目(B2012331)
关键词 体外受精-胚胎移植 卵巢储备功能 黄体期促排卵 克罗米芬 微刺激 In vitro fertilization-embryo transfer Poor ovarian reserve Luteal phase ovarian
  • 相关文献

参考文献14

  • 1Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS): maximizing success rates for assisted reproductive technology patients[J]. Reprod Biol Endoerinol, 2011,982.
  • 2Revelli A, Casano S, Salvagno F, et al. Milder is better? Advantages.and disadvantages of "mild" ovarian stimulation for human in vitro fertilization[J]. Reprod Bio| Endoerinol, 2011,9:25.
  • 3Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of ' poor response to ovarian stimulation for in vitro fertilization the Bologna eriteria[J]. Hum Reprod, 2011,26 1616-1624.
  • 4Karlstr6m PO, Bergh T, Forsberg AS, et al. Prognostic factors for the success rate of embryo freezing[J]. Hum Reprod, 1997,12 1263-1266.
  • 5Edwards RG, Lobo R, Bouchard P. Time to revolutionize ovarian stimulation[J]. Hum Reprod, 1996,11 917-919.
  • 6Munne S, Magli C, Adler A, et al. Treatment-related chromosome abnormalities in human embryos [J ] Hum Reprod, 1997,12 780-784.
  • 7Lamazou F, Fuchs F, Grynberg M, et al. CanceIlation of IVF- ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyper stimulation? An analysis o{ 142 cancellations[J]. J Gynecol Obstet Biol Reprod (Paris) ,2012,41:41-47.
  • 8匡延平.轻刺激——从克罗米芬到来曲唑[J].生殖医学杂志,2008,17(6):431-434. 被引量:30
  • 9匡延平.微刺激促排卵方案的临床研究[J].生殖医学杂志,2010,19(4):356-359. 被引量:24
  • 10Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women[J]. Biol Reprod, 2003,69 1023-1031.

二级参考文献15

  • 1Heijnen EM, Eijkemans MJ, De Klerk C, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non inferiority trial[J]. Lancet, 2007,369(9563): 743-749.
  • 2Goswami SK,Das T,Chattopadhyay TR, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report[J]. Hum Reprod, 2004,19(9):2031-2035.
  • 3Casper RF, Mitwally MF. Aromatase inhibitors for ovulation induction[J]. J Clin Endocrinol Metab, 2006,91 (3) : 760-771.
  • 4Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate[J]. Fertil Steril, 2006,85 (6) : 1761-1765.
  • 5Sereepapong W, Suwajanakorn S, Triratanachat S, et al. Effects of clomiphene citrate on the endometrium of regularly cycling women[J]. Fertil Steril, 2000,7(2) : 287-291.
  • 6Cortinez A, De Carvalho I,Vantman D, et al. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients [J]. Fertil Steril,2005,83(1) : 110 115.
  • 7Bedaiwy MA, Mousa NA, Esfandiari N, et al. Follicular phase dynamics with combined aromatase Inhibitor and follicle stimulating hormone treatment[J]. J Clin Endocrinol Metab, 2007, 92(3) :825-833.
  • 8Aboulghar M.Symposium:Update on prediction and management of OHSS,prevention of OHSS[J].Reprod Biomed Online,2009,19(1):33-42.
  • 9Polinder S,Heijnen EM,Macklon NS,et al.Cost-effectiveness of a mild compared with a standard strategy for IVF:a randomized comparison using cumulative term live birth as the primary endpoint[J].Hum Repord,2008,23(2):316-323.
  • 10de Klerk C,Macklon NS,Heijnen EM,et al.The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy[J].Hum Reprod,2007,22(9):2554-2558.

共引文献49

同被引文献114

引证文献17

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部